We are live on ! Find out more
Parallel Advisors

Parallel Advisors Portfolio holdings

AUM $6.56B Turnover 11.49%
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
Cap. Flow
+$73M
Cap. Flow %
1.87%
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3 years
Top 10 Avg Time Held Equity + Options
2 years
Top 20 Avg Time Held Equity + Options
3.2 years
Avg Time Held Equity only
4.3 years
Top 10 Avg Time Held Equity only
2 years
Top 20 Avg Time Held Equity only
3.2 years

Sector Composition

Rank Sector Weight
1 Miscellaneous 48.08%
2 Technology 16.58%
3 Healthcare 8.56%
4 Financials 6.53%
5 Communication Services 5.05%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
IRLA
3176
IRulya Therapeutics Inc. Common Stock
IRLA
$33.3M
$221 ﹤0.01%
1
-1
-50% -$181
2020 Q1
17 quarters
INTA icon
3177
Intapp
INTA
$3.34B
$220 ﹤0.01%
6
-4
-40% -$136
2022 Q4
6 quarters
SLVP icon
3178
iShares MSCI Global Silver and Metals Miners ETF
SLVP
$855M
$218 ﹤0.01%
19
– –
2022 Q1
9 quarters
VERX icon
3179
Vertex
VERX
$2.22B
$216 ﹤0.01%
+6
New +$193
2024 Q2
0 quarters
CSV icon
3180
Carriage Services
CSV
$575M
$215 ﹤0.01%
8
– –
2023 Q4
2 quarters
UNG icon
3181
United States Natural Gas Fund
UNG
$527M
$209 ﹤0.01%
+12
New +$206
2024 Q2
0 quarters
HOOK icon
3182
DELISTED
HOOKIPA Pharma
HOOK
$207 ﹤0.01%
+35
New +$278
2024 Q2
0 quarters
RYTM icon
3183
Rhythm Pharmaceuticals
RYTM
$6.05B
$205 ﹤0.01%
5
– –
2023 Q4
2 quarters
CCNE icon
3184
CNB Financial Corp
CCNE
$1B
$204 ﹤0.01%
10
– –
2023 Q1
5 quarters
DCOM icon
3185
Dime Commercial Bancshares
DCOM
$1.71B
$204 ﹤0.01%
10
-30
-75% -$565
2023 Q2
4 quarters
OGI icon
3186
Organigram Holdings
OGI
$134M
$203 ﹤0.01%
132
– –
2019 Q3
19 quarters
CPRX icon
3187
DELISTED
Catalyst Pharmaceutical
CPRX
$201 ﹤0.01%
13
– –
2022 Q3
7 quarters
HCSG icon
3188
Healthcare Services Group
HCSG
$1.47B
$201 ﹤0.01%
19
– –
2016 Q4
30 quarters
CRSR icon
3189
Corsair Gaming
CRSR
$1.44B
$199 ﹤0.01%
18
-57
-76% -$646
2021 Q4
10 quarters
AMRX icon
3190
Amneal Pharmaceuticals
AMRX
$6.71B
$197 ﹤0.01%
31
– –
2023 Q4
2 quarters
UFCS icon
3191
United Fire Group
UFCS
$1.42B
$193 ﹤0.01%
9
– –
2023 Q4
2 quarters
APOG icon
3192
Apogee Enterprises
APOG
$864M
$189 ﹤0.01%
+3
New +$186
2024 Q2
0 quarters
HLIT icon
3193
Harmonic Inc
HLIT
$1.16B
$188 ﹤0.01%
16
-17
-52% -$192
2023 Q4
2 quarters
THR icon
3194
DELISTED
Thermon Group Holdings
THR
$185 ﹤0.01%
6
– –
2022 Q3
7 quarters
ZIMV icon
3195
DELISTED
ZimVie
ZIMV
$183 ﹤0.01%
10
– –
2022 Q1
9 quarters
TOLZ icon
3196
ProShares DJ Brookfield Global Infrastructure ETF
TOLZ
$164M
$180 ﹤0.01%
+4
New +$182
2024 Q2
0 quarters
XME icon
3197
State Street SPDR S&P Metals & Mining ETF
XME
$4.02B
$172 ﹤0.01%
3
-148
-98% -$9.06K
2020 Q3
15 quarters
LGND icon
3198
Ligand Pharmaceuticals
LGND
$5.97B
$169 ﹤0.01%
2
– –
2022 Q3
7 quarters
CERE icon
3199
DELISTED
Cerevel Therapeutics Holdings, Inc. Common Stock
CERE
$164 ﹤0.01%
4
– –
2023 Q4
2 quarters
EGO icon
3200
Eldorado Gold
EGO
$9.45B
$163 ﹤0.01%
11
– –
2022 Q1
9 quarters

Similar funds

Parallel Advisors's Q2 2024 Portfolio in Review

As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.

By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.

  • Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
  • Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
  • Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
  • Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
  • Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
  • Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
  • Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.

Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.